Antitumor activity and mechanism of cucurbitacin B in A549/DDP cells
- 16 January 2023
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 396 (6) , 1095-1103
Abstract
Cucurbitacin B (CuB) is a class of tetracyclic triterpenoids isolated from Cucurbitaceae with a wide range of anti-inflammatory and anti-tumor activities, mainly used in hepatitis and hepatocellular carcinoma, while there is relatively little research and application of this drug for lung cancer. In this study, CuB was administered on A549/DDP cells to observe how it affected the cells and their mechanism of action. CuB demonstrated good anti-tumor activity against A549/DDP cells in a dose-dependent manner and caused changes in the hedgehog (Hh) pathway. The results showed that CuB greatly inhibits the proliferation and the invasion of A549/DDP cells, and promoted apoptosis of A549/DDP cells. Meanwhile, it changed the expression of p53-related genes at the RNA and protein level. In conclusion, this experiment provides a theoretical basis for new applications of CuB and new thoughts on the mechanism of its anti-tumor activity, and provides a direction for deep research.Keywords
This publication has 46 references indexed in Scilit:
- Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populationsJournal of Clinical Investigation, 2011
- Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell CycleInternational Journal of Molecular Sciences, 2010
- Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species‐dependent mechanism in human colon adenocarcinoma SW480 cellsMolecular Nutrition & Food Research, 2010
- A GLI1‐p53 inhibitory loop controls neural stem cell and tumour cell numbersThe EMBO Journal, 2009
- Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: The role of p53 and p21Biochemical Pharmacology, 2008
- The Gli code: an information nexus regulating cell fate, stemness and cancerTrends in Cell Biology, 2007
- Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cellsBiochemical Pharmacology, 2007
- Selective Modulation of Hedgehog/GLI Target Gene Expression by Epidermal Growth Factor Signaling in Human KeratinocytesMolecular and Cellular Biology, 2006
- A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2Human Molecular Genetics, 2005
- Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activityOncogene, 2005